A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects. [electronic resource]
Producer: 20130301Description: 136-42 p. digitalISSN:- 1121-2233
- Adjuvants, Immunologic -- administration & dosage
- Adult
- Age Factors
- Aged
- Antibodies, Neutralizing -- blood
- Antibodies, Viral -- blood
- Female
- Hemagglutination Inhibition Tests
- Humans
- Influenza A Virus, H1N1 Subtype -- immunology
- Influenza Vaccines -- administration & dosage
- Influenza, Human -- prevention & control
- Male
- Middle Aged
- Neutralization Tests
- Polysorbates -- administration & dosage
- Squalene -- administration & dosage
- Vaccination -- methods
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.